Rafael
Martínez Monge
Catedrático de Universidad
Publications (153) Rafael Martínez Monge publications
2024
-
Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients
Radiotherapy and Oncology, Vol. 194
-
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 18, pp. 4131-4142
-
Status of head and neck brachytherapy in Spain in 2022
Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 456-460
2023
-
Artificial Intelligence and Radiotherapy: Impact on Radiotherapy Workflow and Clinical Example
Personalized Medicine Meets Artificial Intelligence: beyond “Hype, towards the Metaverse (Springer International Publishing), pp. 145-157
-
ENPP1 Immunobiology as a Therapeutic Target
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 12, pp. 2184-2193
-
Emerging Trends and Future Directions in Skin Cancer Management
Non-melanoma Skin Cancer: Essentials for Oncologists (CRC Press), pp. 407-426
-
Interventional Radiotherapy (Brachytherapy) for the Treatment of Primary Lesions in Nasal Vestibule Malignancies
Malignancies of the Nasal Vestibule: A New Perspective on Classification, Staging, and Treatment (Springer International Publishing), pp. 135-144
-
Intraoperative Radiotherapy in Lung Cancer: Methodology (Electrons or Brachytherapy), Clinical Experiences, and Long-Term Institutional Results
Medical Radiology (Springer Science and Business Media Deutschland GmbH), pp. 605-621
-
Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision
Clinical Oncology, Vol. 35, Núm. 8, pp. e445-e452
2022
-
Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy
Radiotherapy and Oncology, Vol. 170, pp. 159-164
-
Four-fraction ultra-accelerated minimal breast irradiation in early breast cancer: The initial feasibility results of an institutional experience
Brachytherapy, Vol. 21, Núm. 4, pp. 475-486
-
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncology, Vol. 8, Núm. 3
2021
-
Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features
JAMA Network Open, Vol. 4, Núm. 7
-
Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group
Radiotherapy and Oncology, Vol. 154, pp. 128-134
-
Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis
Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941
-
Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ
Journal of Contemporary Brachytherapy, Vol. 12, Núm. 6, pp. 521-532
-
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer[Formula presented]
European Urology, Vol. 80, Núm. 2, pp. 142-146
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550
-
Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1]
Radiotherapy and Oncology
2019
-
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672